Last quarter (Q4 2023), iSpecimen's total revenue was $2.58M, a decrease of -13.05% from the same quarter last year. In Q4, iSpecimen's net income was $-6.42M. See iSpecimen’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 9.93M	$ 9.93M	$ 10.40M	$ 11.14M	$ 8.18M	$ 4.30M
Cost of Revenue	$ 4.82M	$ 4.82M	$ -4.76M	$ -5.25M	$ 3.59M	$ 2.13M
Gross Profit	$ 5.11M	$ 5.11M	$ 2.19M	$ 3.47M	$ 4.60M	$ 2.17M
Operating Expense	$ 11.49M	$ 11.68M	$ 10.38M	$ 8.04M	$ 7.01M	$ 6.05M
Operating Income	$ -8.74M	$ -11.17M	$ -8.19M	$ -4.56M	$ -2.41M	$ -3.88M
Net Non Operating Interest Income Expense	$ -138.92K	$ 323.75K	$ -69.62K	$ -2.09M	$ -2.10M	$ -1.72M
Other Income Expense	$ 39.10K	$ 39.10K	$ -9.78K	$ 2.31M	$ -149.35K	$ 719.86K
Pretax Income	$ -2.80M	$ -1.69M	$ -8.25M	$ -8.96M	$ -4.65M	$ -4.88M
Tax Provision	$ 214.78K	$ 214.78K	-	-	$ 0.00	$ -157.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -13.34M	$ -11.10M	$ -10.25M	$ -8.96M	$ -4.65M	$ -4.73M
Basic EPS	$ -1.23	$ -1.23	$ -1.16	$ -2.09	$ -0.72	$ -1.11
Diluted EPS	$ -1.21	$ -1.23	$ -1.16	$ -2.09	$ -0.72	$ -1.11
Basic Average Shares	$ 36.17M	$ 9.04M	$ 8.84M	$ 4.29M	$ 6.49M	$ 4.24M
Diluted Average Shares	$ 36.17M	$ 9.04M	$ 8.84M	$ 4.29M	$ 6.49M	$ 4.24M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 16.31M	$ 16.50M	$ 5.62M	$ 2.79M	$ 10.59M	$ 8.18M
Net Income From Continuing And Discontinued Operation	$ -11.10M	$ -11.10M	$ -10.25M	$ -8.96M	$ -4.65M	$ -4.73M
Normalized Income	$ 1.65M	$ 2.14M	-	-	$ -4.49M	$ -5.26M
Interest Expense	-	-	-	-	$ 2.10M	$ 1.72M
EBIT	$ -2.44M	$ -1.67M	$ -8.17M	$ -6.87M	$ -2.56M	$ -3.16M
EBITDA	$ -497.45K	$ 263.79K	$ -6.89M	$ -4.99M	$ -1.74M	$ -2.52M

Currency in USD

iSpecimen Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing